BE904152A - Formulation a liberation prolongee contenant des alcaloides de l'ergot de seigle. - Google Patents

Formulation a liberation prolongee contenant des alcaloides de l'ergot de seigle.

Info

Publication number
BE904152A
BE904152A BE1/011431A BE1011431A BE904152A BE 904152 A BE904152 A BE 904152A BE 1/011431 A BE1/011431 A BE 1/011431A BE 1011431 A BE1011431 A BE 1011431A BE 904152 A BE904152 A BE 904152A
Authority
BE
Belgium
Prior art keywords
sustained release
release formulation
formulation containing
ergot alkaloids
containing rye
Prior art date
Application number
BE1/011431A
Other languages
English (en)
Original Assignee
Sandoz Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB858502889A external-priority patent/GB8502889D0/en
Priority claimed from GB858517604A external-priority patent/GB8517604D0/en
Application filed by Sandoz Sa filed Critical Sandoz Sa
Publication of BE904152A publication Critical patent/BE904152A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Formulation à libération prolongée pour l'administration par voie orale comprenant un alcaloide de l'ergot de seigle 9,10-dihydrogéné, une substance gonflante hydrophile pharmaceutiquement acceptable et une matière grasse inerte pharmaceutiquement acceptable. Cette formulation se présente sous forme d'une dose unitaire, administrable une fois par jour.
BE1/011431A 1985-02-05 1986-02-03 Formulation a liberation prolongee contenant des alcaloides de l'ergot de seigle. BE904152A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB858502889A GB8502889D0 (en) 1985-02-05 1985-02-05 Co-dergocrine compositions
GB858517604A GB8517604D0 (en) 1985-07-12 1985-07-12 Dihydroergotamine compositions

Publications (1)

Publication Number Publication Date
BE904152A true BE904152A (fr) 1986-08-04

Family

ID=26288767

Family Applications (1)

Application Number Title Priority Date Filing Date
BE1/011431A BE904152A (fr) 1985-02-05 1986-02-03 Formulation a liberation prolongee contenant des alcaloides de l'ergot de seigle.

Country Status (24)

Country Link
JP (1) JPS61183225A (fr)
KR (1) KR920010388B1 (fr)
AU (1) AU597570B2 (fr)
BE (1) BE904152A (fr)
CA (1) CA1263087A (fr)
CH (1) CH667592A5 (fr)
CY (1) CY1604A (fr)
DE (1) DE3602577A1 (fr)
DK (1) DK167138B1 (fr)
ES (1) ES8800040A1 (fr)
FR (1) FR2576787B1 (fr)
GB (1) GB2170407B (fr)
GR (1) GR860310B (fr)
HK (1) HK57191A (fr)
HU (1) HU195729B (fr)
IE (1) IE59293B1 (fr)
IT (1) IT1191255B (fr)
LU (1) LU86289A1 (fr)
NL (1) NL8600161A (fr)
NZ (1) NZ215020A (fr)
PH (1) PH23384A (fr)
PT (1) PT81954B (fr)
SE (1) SE8600496L (fr)
SG (1) SG56191G (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2610827B1 (fr) * 1987-02-18 1991-09-13 Pf Medicament Comprime de dihydroergotamine (d.h.e.) du type a matrice hydrophile et son procede de fabrication
SI8710406B (sl) * 1987-03-11 1998-08-31 Lek Tablete s podaljšanim delovanjem na osnovi hidroksipropilmetilceluloze z veliko molsko maso in postopek za njihovo pripravo
RU2256454C2 (ru) * 1999-12-03 2005-07-20 Полишем С.А. Способы получения фармацевтических композиций алкалоидов спорыньи с пролонгированным действием, характеризующихся улучшенной биодоступностью, и содержащие указанные алкалоиды композиции
US7771746B2 (en) 1999-12-03 2010-08-10 Polichem Sa Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof
ATE383855T1 (de) 2000-05-12 2008-02-15 Meracol Corp Ltd Behandlung von reizkolon-syndrom oder -krankheit
NZ504526A (en) * 2000-05-12 2003-05-30 Meracol Corp Ltd Treating herpes simplex symptoms using a mixture of cetyl myristate and cetyl palmitate
US20030153620A1 (en) 2000-05-12 2003-08-14 Meakin Timothy David Treating eczema and/or psoriasis
ATE381327T1 (de) * 2000-05-12 2008-01-15 Meracol Corp Ltd Cethylmyristat und cetylpalmitat zurbehandlung von ekzemen und/oder psoriasis
WO2003026640A1 (fr) * 2001-09-28 2003-04-03 Meracol Corporation Limited Traitement d'allergies alimentaires et/ou d'intolerances alimentaires
CN111297815B (zh) * 2020-04-29 2022-04-15 宝利化（南京）制药有限公司 一种甲磺酸二氢麦角碱缓释片及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3147187A (en) * 1962-09-10 1964-09-01 Don Hall Lab Sustained release pharmaceutical
CH630257A5 (en) * 1975-03-17 1982-06-15 Hoffmann La Roche Sustained release formulation
DE3124983A1 (de) * 1981-06-25 1983-01-20 Meditest Inst Fuer Medizinisch Arzneiformen zur oralen verabreichung
CH649300A5 (de) * 1981-08-07 1985-05-15 Sandoz Ag Ergopeptinderivate, ihre herstellung und verwendung.
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
DE3303616A1 (de) * 1982-02-12 1983-08-25 Sandoz-Patent-GmbH, 7850 Lörrach Mutterkornalkaloide, verfahren zu deren herstellung sowie diese verbindungen enthaltende pharmazeutische zubereitungen
US4421736A (en) * 1982-05-20 1983-12-20 Merrel Dow Pharmaceuticals Inc. Sustained release diethylpropion compositions
JPS604120A (ja) * 1983-06-22 1985-01-10 Shionogi & Co Ltd 作用持続型ピナシジル製剤
GB2154874B (en) * 1984-02-29 1987-11-04 Sandoz Ltd Bromoscriptine compositions
GB8413795D0 (en) * 1984-05-30 1984-07-04 Sandoz Ltd Organic compounds

Also Published As

Publication number Publication date
GB2170407B (en) 1988-10-26
PH23384A (en) 1989-07-26
ES8800040A1 (es) 1987-10-16
GR860310B (en) 1986-05-27
NZ215020A (en) 1989-07-27
IE59293B1 (en) 1994-02-09
IT8647620A0 (it) 1986-02-05
JPS61183225A (ja) 1986-08-15
AU5294286A (en) 1986-08-14
ES551635A0 (es) 1987-10-16
SE8600496D0 (sv) 1986-02-04
SG56191G (en) 1991-08-23
KR860006265A (ko) 1986-09-09
DK52086A (da) 1986-08-06
DE3602577A1 (de) 1986-08-28
CA1263087A (fr) 1989-11-21
IT1191255B (it) 1988-02-24
DK167138B1 (da) 1993-09-06
IE860291L (en) 1986-08-05
GB2170407A (en) 1986-08-06
HK57191A (en) 1991-08-02
HUT41984A (en) 1987-06-29
GB8602602D0 (en) 1986-03-12
PT81954B (pt) 1988-07-01
LU86289A1 (fr) 1986-09-02
SE8600496L (sv) 1986-08-06
KR920010388B1 (ko) 1992-11-27
AU597570B2 (en) 1990-06-07
CY1604A (en) 1992-04-03
DK52086D0 (da) 1986-02-03
FR2576787B1 (fr) 1990-01-12
PT81954A (en) 1986-03-01
HU195729B (en) 1988-07-28
CH667592A5 (de) 1988-10-31
FR2576787A1 (fr) 1986-08-08
NL8600161A (nl) 1986-09-01

Similar Documents

Publication Publication Date Title
IL96900A0 (en) Pharmaceutical composition containing naproxen
RU2000111506A (ru) Таблетки с пролонгированным выделением для лечения болезни паркинсона
FR2673538B1 (fr) Composition a base de 3-[2-(dimethylamino)ethyl]-n-methyl-1h-indole-5 methanesulfonamide pour l'administration buccale.
IL111519A (en) Sustained release tablets containing acetaminophen and methods for the preparation thereof
NO883667L (no) Kapsel for farmasoeytisk virksomme innholdsstoffer av en droge.
IL91656A0 (en) Pharmaceutical composition containing a benzodiazepine derivative
NO166448C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidindioner.
MY125662A (en) Pharmaceutical formulations containing darifenacin
NL970006I1 (nl) Gebruik van indolon-derivaten voor het bereiden van geneesmiddelen ter behandeling van de ziekte vanParkinson.
FR2523443B1 (fr) Nouvelles formulations pharmaceutiques contenant le coenzyme q10 adaptees pour l'administration topique
BE904152A (fr) Formulation a liberation prolongee contenant des alcaloides de l'ergot de seigle.
MY100998A (en) Pharmaceutical formulations
KR880002515A (ko) 흡수 및 작용이 빠른 설린다크 또는 나트륨 설린다크와 염기의 혼합물
EP1004315A4 (fr) Preventifs et/ou medicaments contre le lupus erythemateux systemique, contenant un anticorps anti-recepteur d'il-6 comme ingredient actif
KR880007074A (ko) 의약품
KR880007073A (ko) 의 약 품
IE821489L (en) Pharmaceutical formulations
MY124465A (en) Reduction of infarct volume using citicoline
FR2660192B1 (fr) Formulation liposomiales pour l'administration topique ou vaginale de medicaments.
BG99167A (bg) Фармацевтични състави за ректално приложение на адкилсулфонамиди- агонисти на 5-нт долу 1
ZA828639B (en) Novel triazoloquinazolinones, their preparation and pharmaceutical formulations containing these compounds
FR2444463A1 (fr) Nouvelles compositions pharmaceutiques solides a base d'alcaloides de l'ergot de seigle, permettant une liberation controlee de ce principe actif
NO307496B1 (no) Anvendelse av en <delta>-opioid antagonist for fremstilling av et antitussivt middel
US4122177A (en) Method of treating oligospermia and asthenospermia
GB1535778A (en) Compounds useful in treatment of unipolar depression

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: SANDOZ S.A.

Effective date: 19940228